DLYT yields 2000000.00% · PFE yields 6.13%● Live data
📍 DLYT pulled ahead of the other in Year 1
Combined, DLYT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DLYT + PFE for your $10,000?
Dais Corporation, a nano-structured polymer technology materials company, develops and commercializes products using its nanomaterial. The company offers Aqualyte, a nanomaterial platform made from commercially available polymer resin and industrial grade solvents, which are mixed using a proprietary process with traditional industrial equipment; and ConsERV, a fixed plate energy recovery ventilator that is useful in meeting building indoor fresh air requirements while saving energy and lowering emissions for various forms of heating, ventilation, and air conditioning equipment. It also provides NanoClear, a water clean-up process useful in the creation of potable water from contaminated water, including industrial process wastewater sea, brackish, or wastewater; and PolyCool and NanoAir products, as well as licenses its nano-structure polymer technology. The company was formerly known as Dais Analytic Corporation Inc. and changed its name to Dais Corporation in February 2019. Dais Corporation was incorporated in 1993 and is headquartered in Odessa, Florida.
Full DLYT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.